insulin aspart protamine and insulin aspart
| Brand name | Novolog Mix 70/30 |
|---|---|
| Active ingredient | insulin aspart protamine and insulin aspart |
| Strength | 700UNITS/10ML (70UNITS/ML); 300UNITS/10ML (30UNITS/ML) |
| Dosage form | Injectable Suspension |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | November 2001 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.